Nuvectis Pharma, Inc. Money Market Funds, at Carrying Value
Nuvectis Pharma, Inc. (NVCT) had Money Market Funds, at Carrying Value of $30.80 million as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2026-02-11
- 2025-12-31: Money Market Funds, at Carrying Value $30.80M.
- 2024-12-31: Money Market Funds, at Carrying Value $18.20M.
- 2023-12-31: Money Market Funds, at Carrying Value $17.10M.
| Period end | Money Market Funds, at Carrying Value |
|---|---|
| 2025-12-31 | $30.80M 10-K · filed 2026-02-11 |
| 2024-12-31 | $18.20M 10-K · filed 2026-02-11 |
| 2023-12-31 | $17.10M 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |